113UrtziVBaja.jpg picture
 
Firma en Digital.CSIC (*)
Garaigorta, Urtzi
 
Centro o Instituto
CSIC - Centro Nacional de Biotecnología (CNB)
 
Departamento
Molecular and Cellular Biology
 
Especialización
Antiviral compound identification and characterization. shRNA-based genetic screening. Antibody neutralization assays. Characterization of host response to infection.
 
Email
ugaraigorta@cnb.csic.es
 
 
Perfil en Google Scholar
 
WoS ResearcherID - Publons
 
Scopus AuthorID
 
 
Otros - Academia.edu
 
Otros - ResearchGate
 
Otros identificadores (con url)
 

Publications

Results 1-20 of 20 (Search time: 0.037 seconds).

RightsPreviewIssue DateTitleAuthor(s)Type
1openAccess26-Nov-2020Antiviral drugs targeting endosomal membrane proteins inhibit distant animal and human pathogenic virusesGalindo Estrada, Ignacio; Garaigorta, Urtzi ; Lasala, Fátima; Cuesta-Geijo, Miguel Ángel CSIC ORCID; Bueno, P.; Gil, Carmen CSIC ORCID ; Delgado, Rafael; Gastaminza, Pablo CSIC ORCID; Alonso, C. CSIC ORCIDartículo
2openAccessJournal of Virology-2021-García-Arriaza-JVI.02260-20.full.pdf.jpg7-Jan-2021COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in miceGarcía-Arriaza, Juan CSIC ORCID ; Garaigorta, Urtzi ; Pérez, Patricia; Lázaro-Frías, Adrián; Zamora, Carmen; Gastaminza, Pablo CSIC ORCID; Fresno, Carlos del; Casasnovas, José María CSIC ORCID ; Sorzano, Carlos Óscar S.; Sancho, David; Esteban, Mariano CSIC ORCID artículo
3openAccessijms-23-03448-v2.pdf.jpg22-Mar-2022Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport FunctionOliva, María A. CSIC ORCID ; Tosat-Bitrian, Carlota CSIC ORCID ; Barrado-Gil, Lucía CSIC ORCID; Bonato, Francesca CSIC ORCID; Galindo Barreales, Inmaculada; Garaigorta, Urtzi ; Álvarez-Bernad, Beatriz CSIC; París-Ogáyar, Rebeca CSIC ORCID; Lucena-Agell, Daniel CSIC ORCID ; Giménez-Abián, Juan F. CSIC ; García-Dorival, Isabel; Urquiza, Jesús; Gastaminza, Pablo CSIC ORCID; Díaz, José Fernando CSIC ORCID ; Palomo, Valle CSIC ORCID ; Alonso Martí, Covadongaartículo
4closedAccessaccesoRestringido.pdf.jpg2014Emergent properties of the interferon-signalling network may underlie the success of hepatitis C treatmentPranesh Padmanabhan; Garaigorta, Urtzi ; Dixit, Narendra M.artículo
5openAccessGenetic Analysis of Influenza_Garaigorta_Art_2005.pdf.jpgDec-2005Genetic Analysis of Influenza Virus NS1 Gene: a Temperature-Sensitive Mutant Shows Defective Formation of Virus ParticlesGaraigorta, Urtzi ; Falcón, Ana; Ortín, Juan CSIC ORCIDartículo
6closedAccessaccesoRestringido.pdf.jpgMay-2018HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric miceKruse, Robert L.; Shum, Thomas; Tashiro, Haruko; Barzi, Mercedes; Yi, Zhongzhen; Whitten-Bauer, Christina; Legras, Xavier; Bissig-Choisat, Beatrice; Garaigorta, Urtzi ; Gottschalk, Stephen M.; Bissig, Karl-Dimiterartículo
7openAccessHepatitis_B_Virus_Gómez-Moreno_Art2017.pdf.jpg2017Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the InfectionGómez-Moreno, Andoni; Garaigorta, Urtzi artículo de revisión
8closedAccessaccesoRestringido.pdf.jpg17-Dec-2009Hepatitis C Virus Blocks Interferon Effector Function by Inducing Protein Kinase R PhosphorylationGaraigorta, Urtzi ; Chisari, Francis V.artículo
9openAccesspharmaceuticals-14-00332-v3.pdf.jpg6-Apr-2021Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening MethodsGinex, Tiziana CSIC ORCID ; Garaigorta, Urtzi ; Ramírez, David; Castro, Victoria; Nozal, Vanesa CSIC ORCID; Maestro, Inés CSIC ORCID; Garcia-Carceles, Javier CSIC ORCID; Campillo, Nuria E. CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Gastaminza, Pablo CSIC ORCID; Gil, Carmen CSIC ORCID artículo
10openAccessIdentification_Whitten_PV_Art2020.pdf.jpg2020Identification of Aquarius and Senataxin as Restriction Host Factors for Hepatitis B Virus InfectionWhitten-Bauer, Christina; Gómez-Moreno, Andoni; Garaigorta, Urtzi artículo
11openAccessAntiviral Research_García-Dorival_2021.pdf.jpgOct-2021Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular targetGarcía-Dorival, Isabel; Cuesta-Geijo, Miguel Ángel CSIC ORCID; Barrado-Gil, Lucía CSIC ORCID; Galindo Barreales, Inmaculada; Garaigorta, Urtzi ; Urquiza, Jesús; Puerto, Ana del CSIC; Campillo, Nuria E. CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Gastaminza, Pablo CSIC ORCID; Gil, Carmen CSIC ORCID ; Alonso Martí, Covadongaartículo
12closedAccessaccesoRestringido.pdf.jpgApr-2016In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotidesBillioud, Gaetan; Kruse, Robert L.; Carrillo, Melissa; Whitten-Bauer, Christina; Gao, Dacao; Kim, Aneeza; Chen, Leon; McCaleb, Michael L.; Crosby, Jeffrey R.; Hamatake, Robert; Hong, Zhi; Garaigorta, Urtzi ; Swayze, Eric; Bissig, Karl-Dimiter; Wieland, Stefanartículo
13openAccessInterferon-β_Marcos_Villar_Art2020.pdf.jpg2020Interferon-β Stimulation Elicited by the Influenza Virus Is Regulated by the Histone Methylase Dot1L through the RIG-I-TRIM25 Signaling AxisMarcos-Villar, Laura CSIC ORCID ; Nistal-Villán, Estanislao; Zamarreño, Noelia; Garaigorta, Urtzi ; Gastaminza, Pablo CSIC ORCID; Nieto, Ameliaartículo
14openAccessMutation analysis_Garaigorta_Art_2007.pdf.jpg15-Jul-2007Mutation analysis of a recombinant NS replicon shows that influenza virus NS1 protein blocks the splicing and nucleo-cytoplasmic transport of its own viral mRNAGaraigorta, Urtzi ; Ortín, Juan CSIC ORCIDartículo
15openAccessfimmu-13-863831.pdf.jpg25-Apr-2022Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than OmicronCasasnovas, José María CSIC ORCID ; Margolles, Yago; Noriega, María A.; Guzmán, María; Arranz, Rocío; Melero, Roberto CSIC ORCID; Casanova, Mercedes; Corbera, Juan Alberto; Jiménez de Oya, Nereida; Gastaminza, Pablo CSIC ORCID; Garaigorta, Urtzi ; Saiz Calahorra, Juan Carlos; Martín-Acebes, M. A.; Fernández, Luis Ángel CSIC ORCID artículo
16openAccesspharmaceuticals-14-01048-v3.pdf.jpg15-Oct-2021SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent AntiviralJiménez-Alemán, G. H.; Castro, Victoria; Longdaitsbehere, Addis; Gutiérrez-Rodríguez, Marta CSIC ORCID ; Garaigorta, Urtzi ; Solano, Roberto CSIC ORCID; Gastaminza, Pablo CSIC ORCIDartículo
17closedAccessaccesoRestringido.pdf.jpg18-Oct-2012Short-Range Exosomal Transfer of Viral RNA from Infected Cells to Plasmacytoid Dendritic Cells Triggers Innate ImmunityDreux, Marlène; Garaigorta, Urtzi ; Boyd, Bryan; Décembre, Elodie; Chung, Josan; Whitten-Bauer, Christina; Wieland, Stefan; Chisari, Francis V.artículo
18openAccessStructure and inhibition_Fabrega_PV_Art2022.pdf.jpgDec-2022Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404Fàbrega-Ferrer, Montserrat CSIC ORCID; Herrera Morande, Alejandra Margarita CSIC; Muriel-Goñi, Sara CSIC; Pérez-Saavedra, Julia CSIC ORCID; Bueno, P.; Castro, Victoria; Garaigorta, Urtzi ; Gastaminza, Pablo CSIC ORCID; Coll, Miquel CSIC ORCID artículo
19openAccessfimmu-12-748103.pdf.jpg18-Nov-2021The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines ImmunogenicityFresno, Carlos del; García-Arriaza, Juan CSIC ORCID ; Martínez-Cano, Sarai; Heras-Murillo, Ignacio; Jarit-Cabanillas, Aitor; Amores-Iniesta, Joaquín; Brandi, Paola; Dunphy, Gillian; Suay-Corredera, Carmen; Pricolo, Maria Rosaria; Vicente, Natalia; López-Perrote, Andrés CSIC ORCID; Cabezudo, Sofía CSIC ORCID; González-Corpas, Ana; Llorca, Óscar CSIC ORCID; Alegre-Cebollada, Jorge; Garaigorta, Urtzi ; Gastaminza, Pablo CSIC ORCID; Esteban, Mariano CSIC ORCID ; Sancho, Davidartículo
20openAccesscells-08-01555-v3.pdf.jpg2-Dec-2019The Host Factor Erlin-1 is Required for Efficient Hepatitis C Virus InfectionWhitten-Bauer, Christina; Chung, Josan; Gómez-Moreno, Andoni; Gomollón-Zueco, Pilar CSIC ORCID; Huber, Michael D.; Gerace, Larry; Garaigorta, Urtzi artículo